Suzanne Louise Topalian
CIK: 0002159860
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
VIR
Vir Biotechnology, Inc.
Director
Discretionary Trading P&L
Holdings
About Topalian Suzanne Louise
Topalian Suzanne Louise (SEC CIK 0002159860) files insider reports with the SEC as Director of Vir Biotechnology, Inc. (VIR).
Signal8 holds 2 ownership filings by Topalian Suzanne Louise (1 Form 3, 1 Form 4), filed on Oct 28, 2026. Those filings report 2 transactions, the latest on Oct 27, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Topalian Suzanne Louise's filings is in SAN FRANCISCO, CA.
Recent filings by Topalian Suzanne Louise
- Oct 27, 2026: Grants or awards of VIR shares (2 lines, Form 4, code A).
Other insiders filing for Vir Biotechnology, Inc. (VIR)
- Sawaf Aziz, EVP, Chief Financial Officer
- MORE ROBERT J, Director
- Coughlin Timothy, Director
- Napolitano Janet, Director
- Sabatini Brent, SVP, Chief Accounting Officer
- Sigal Charles Elliott, Director